UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.028

Sortiert nach

SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant

World journal of gastroenterology : WJG, 2020-04, Vol.26 (14), p.1546-1553

2020

Volltextzugriff (PDF)

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant

Annals of hepatology, 2017-05, Vol.16 (3), p.375-381

2017

Volltextzugriff (PDF)

Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients

Oncology, 2015-01, Vol.88 (1), p.57-68

2015

Volltextzugriff (PDF)

Opportunities to address gaps in early detection and improve outcomes of liver cancer

JNCI cancer spectrum, 2023-05, Vol.7 (3)

2023

Volltextzugriff (PDF)

Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID‐19 in solid organ transplant recipients

American journal of transplantation, 2022-08, Vol.22 (8), p.2083-2088

2022

Volltextzugriff (PDF)

Post-liver transplantation patient experience

Journal of hepatology, 2023-06, Vol.78 (6), p.1234-1244

2023

Volltextzugriff (PDF)

Identification of Quantifiable Predictors of Relapse in Patients with Alcohol‐Associated Liver Disease

Hepatology communications, 2021-07, Vol.5 (7), p.1156-1164

2021

Volltextzugriff (PDF)

Chasing equity: The evolving effects of MMaT-3 policy on outcomes of liver transplantation for hepatocellular carcinoma

Liver transplantation, 2023-10, Vol.29 (10), p.1027-1028

2023

Volltextzugriff (PDF)

Introducing the new Controversies in Liver Transplantation Corner

Liver transplantation, 2024-07, Vol.30 (7), p.678-678

2024

Volltextzugriff (PDF)

Future Therapies of Hepatic Encephalopathy

Clinics in liver disease, 2024-05, Vol.28 (2), p.331-344

2024

Volltextzugriff (PDF)

Nonviral or Drug-Induced Etiologies of Acute-on-Chronic Liver Failure (Autoimmune, Vascular, and Malignant)

Clinics in liver disease, 2023-08, Vol.27 (3), p.649-657

2023

Volltextzugriff (PDF)

Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats

Clinics in liver disease, 2023-02, Vol.27 (1), p.117-131

2023

Volltextzugriff (PDF)

National survey of second opinions for hospitalized patients in need of liver transplantation

Liver transplantation, 2023-12, Vol.29 (12), p.1264-1271

2023

Volltextzugriff (PDF)

Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation

Epidemiology (Cambridge, Mass.), 2023-05, Vol.34 (3), p.365

2023

Volltextzugriff (PDF)

If hepatitis C therapy is so great, why isn't everyone doing it?

American journal of transplantation, 2018-10, Vol.18 (10), p.2382-2383

Brown, Robert S.

2018

Volltextzugriff (PDF)

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

Journal of clinical oncology, 2008-06, Vol.26 (18), p.2992-2998

2008

Volltextzugriff (PDF)

Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals

Liver transplantation, 2023-12, Vol.29 (12), p.1262-1263

2023

Volltextzugriff (PDF)

Non‐invasive markers of inflammation in alcohol‐associated liver disease: A scoping review

Journal of gastroenterology and hepatology, 2024-02, Vol.39 (2), p.245-255

2024

Volltextzugriff (PDF)

Beyond Survival: Adverse Events and Care Delivery Outcomes after Early Liver Cancer Treatment in a Nationally Representative Cohort

Journal of vascular and interventional radiology, 2023-11, Vol.34 (11), p.1997-2005.e3

2023

Volltextzugriff (PDF)

Transplantation for Alcoholic Hepatitis — Time to Rethink the 6-Month “Rule”

The New England journal of medicine, 2011-11, Vol.365 (19), p.1836-1838

Brown, Robert S

2011

Volltextzugriff (PDF)

Uncontrolled diabetes mellitus increases risk of infection in patients with advanced cirrhosis

Digestive and liver disease, 2021-04, Vol.53 (4), p.445-451

2021

Volltextzugriff (PDF)

Mycophenolate mofetil for drug-induced vanishing bile duct syndrome

World journal of gastroenterology : WJG, 2007-12, Vol.13 (45), p.6087

2007

Volltextzugriff (PDF)

Early initiation of glecaprevir/pibrentasvir after transplantation of HCV‐viremic kidneys into HCV‐negative recipients is associated with normalization in the altered inflammatory milieu

Clinical transplantation, 2023-04, Vol.37 (4), p.e14926-n/a

2023

Volltextzugriff (PDF)

Predictors for Early Liver Cancer Survival After Ablation and Surgical Resection: A Surveillance, Epidemiology, and End Results Program-Medicare Study

Journal of the American College of Radiology, 2024-02, Vol.21 (2), p.295-308

2024

Volltextzugriff (PDF)

1 – 25 von 2.028

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.874)
Mit Volltextzugriff
(1.680)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.604)
Life Sciences & Biomedicine
(1.464)
Humans
(1.438)
Male
(842)
Female
(837)
Middle Aged
(599)
Aged
(526)
Biological And Medical Sciences
(471)
Adult
(465)
Medical Sciences
(418)
Neurosciences & Neurology
(383)
Animals
(264)
Clinical Neurology
(248)
Neurology
(239)
Surgery
(235)
Aged, 80 And Over
(231)
Risk Factors
(219)
Neurosciences
(214)
Gastroenterology & Hepatology
(196)
Cardiovascular System & Cardiology
(169)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant

Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients

Opportunities to address gaps in early detection and improve outcomes of liver cancer

Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID‐19 in solid organ transplant recipients

Post-liver transplantation patient experience

Identification of Quantifiable Predictors of Relapse in Patients with Alcohol‐Associated Liver Disease

Chasing equity: The evolving effects of MMaT-3 policy on outcomes of liver transplantation for hepatocellular carcinoma

Introducing the new Controversies in Liver Transplantation Corner

Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis

Future Therapies of Hepatic Encephalopathy

Nonviral or Drug-Induced Etiologies of Acute-on-Chronic Liver Failure (Autoimmune, Vascular, and Malignant)

Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats

National survey of second opinions for hospitalized patients in need of liver transplantation

Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation

If hepatitis C therapy is so great, why isn't everyone doing it?

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals

Non‐invasive markers of inflammation in alcohol‐associated liver disease: A scoping review

Beyond Survival: Adverse Events and Care Delivery Outcomes after Early Liver Cancer Treatment in a Nationally Representative Cohort

Transplantation for Alcoholic Hepatitis — Time to Rethink the 6-Month “Rule”

Uncontrolled diabetes mellitus increases risk of infection in patients with advanced cirrhosis

Mycophenolate mofetil for drug-induced vanishing bile duct syndrome

Early initiation of glecaprevir/pibrentasvir after transplantation of HCV‐viremic kidneys into HCV‐negative recipients is associated with normalization in the altered inflammatory milieu

Predictors for Early Liver Cancer Survival After Ablation and Surgical Resection: A Surveillance, Epidemiology, and End Results Program-Medicare Study

Suchergebnisse filtern